Johnson & Johnson will acquire biotech company Firefly Bio for $1 billion in cash

Mars Finance News: On June 8, it was reported that Johnson & Johnson issued a statement saying that it has reached a final agreement to acquire the biotechnology company Firefly Bio for $1 billion in cash. The transaction is still subject to regulatory approval and is expected to be completed later this year.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned